does tirzepatide cause eye problems Ozempic and other weight-loss drugs linked to rare but serious conditions Blurry Vision from GLP-1 Medications:

These medications are now recommended for patients with type 2 diabetes and chronic kidney disease to reduce cardiovascular risk and protect renal function

November 2015

Every injection is administered by a skilled provider with extensive training and expertise

Further, a modified version of sermorelin (replacement of methionine with norleucine at position 27) has been reported to increase skin thickness in both men and women after 16 weeks of therapy involving 10mcg/kg of bodyweight daily

Value in Health 27(6):S55S56 Kornelius E et al (2024) The risk of depression, anxiety, and suicidal behavior in patients with obesity on glucagon like peptide-1 receptor agonist therapy